


Ask a doctor about a prescription for Espumisan 100 mg/ml
100 mg/ml, oral drops, emulsion
Simeticone
This medicine should always be used exactly as described in this leaflet for the patient or as advised by your doctor or pharmacist.
This medicine is used for the symptomatic treatment of bloating (gas accumulation) in all age groups. It reduces the surface tension of gas bubbles contained in food masses and in the mucous membrane of the gastrointestinal tract, causing them to burst. This allows the released gases to be absorbed by the intestinal wall or eliminated from the gastrointestinal tract as a result of intestinal peristalsis.
Espumisan 100 mg/ml is used:
Without consulting a doctor:
After consulting a doctor:
If there is no improvement after 3 days or if the patient feels worse, they should consult their doctor.
Before starting to use Espumisan 100 mg/ml, you should discuss it with your doctor or pharmacist.
In case of new symptoms, a doctor's visit is necessary. This medicine should not be used for more than 14 days without consulting a doctor. If the symptoms have not subsided within this time, you should consult your doctor.
When using the medicine in infants and children, you should consult a doctor.
No interactions with other medicines are known.
There are no special requirements.
If the patient is pregnant or breastfeeding, thinks she may be pregnant, or plans to have a child, she should consult her doctor or pharmacist before using this medicine.
Due to the lack of clinical trials on the use of the medicine during pregnancy, it is not recommended to use this medicine during pregnancy and breastfeeding.
No special precautions are required.
This medicine contains less than 1 mmol (23 mg) of sodium per ml, which means the medicine is considered "sodium-free".
This medicine should always be used exactly as described in this leaflet for the patient or as advised by your doctor or pharmacist. In case of doubts, you should consult your doctor or pharmacist.
The dose of Espumisan 100 mg/ml can be measured in two ways.
Depending on the dose size, the dose can be measured using:
Dosing
The dose of the medicine should be selected based on the severity of the symptoms.
The recommended dose is:
Without consulting a doctor in gastrointestinal disorders associated with excessive gas accumulation in the gastrointestinal tract.
This medicine can also be given to patients in the postoperative period after consulting a doctor.
This medicine can be taken directly before, during, or after a meal, and if necessary, also before bedtime.
Treatment should be continued until the symptoms subside, but not longer than 14 days without consulting a doctor.
This medicine can be used for a longer period only if advised by a doctor. See also section 2: "Warnings and precautions".
Before diagnostic examinations of the abdominal cavity according to the doctor's instructions.
1 ml 3 times a day the day before the examination, after meals, and 1 ml in the morning on the day of the examination
As an addition to the contrast agent suspension after consulting a doctor.
2 ml to 4 ml per 1 liter of contrast agent used during the examination with double contrast
Before stomach and small intestine examination (endoscopy) after consulting a doctor.
2 to 3 ml before the examination
If necessary, a few more ml of the emulsion can be poured into the endoscope during the examination to reduce foaming of the gastrointestinal tract contents
Method of administration
Shake before use!
Using a dropper (10-25 drops)
To measure the correct number of drops, the bottle should be held vertically, opening downwards.
25 drops correspond to 1 ml of emulsion (which corresponds to 100 mg of simeticone).
Using a measuring cup
To enable dosing, a measuring cup with a scale in ml is included in the packaging, attached to the cap of the bottles containing 30 and 50 ml. If necessary (e.g., to administer a dose larger than 25 drops), the measuring cup can be detached and used instead of the dropper.
Note: Due to the risk of swallowing, the measuring cup should be stored in a place inaccessible to children.
| Age | Dosing in drops (using a dropper) |
| Infants |
|
| 10 drops 3 to 5 times a day |
| 10 to 20 drops 3 to 5 times a day |
| Adolescents and adults | 20 drops 3 to 5 times a day |
Taking a large dose of this medicine will not cause poisoning. Even large doses of this medicine are well tolerated. The active substance of this medicine is simeticone, which physically reduces foaming of the gastrointestinal tract contents. Simeticone is not absorbed and does not undergo chemical or enzymatic transformations in the gastrointestinal tract.
A missed dose of the medicine can be taken at any time.
After stopping the use of the medicine, symptoms may recur.
In case of any further doubts related to the use of this medicine, you should consult your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
For medicines containing simeticone, hypersensitivity reactions, including urticaria, rash, skin redness, itching, allergic dermatitis, and other skin reactions, have been reported. The frequency cannot be estimated from the available data (frequency unknown).
If you experience any side effects, including any side effects not listed in this leaflet, you should inform your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C
02-222 Warsaw
tel.: + 48 (22) 49 21 301
fax: + 48 (22) 49 21 309
website: https://smz.ezdrowie.gov.pl
By reporting side effects, you can help gather more information on the safety of the medicine.
The medicine should be stored in a place invisible and inaccessible to children.
This medicine should not be used after the expiry date stated on the packaging. The expiry date refers to the last day of the specified month.
There are no special storage temperature requirements. Do not store in the refrigerator or freeze.
This medicine can be used for 6 months after the first opening of the packaging.
Medicines should not be disposed of via wastewater or household waste. You should ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Espumisan 100 mg/ml is simeticone.
1 ml of oral emulsion contains 100 mg of simeticone.
The other ingredients are:
Macrogol stearate, glycerol monostearate 40-55, sorbic acid (E 200), sodium hydroxide (E 524), sodium chloride, carbomers, sodium citrate (E 331), sucralose (E 955), purified water.
Espumisan 100 mg/ml is a milky white to yellowish emulsion with low viscosity in brown glass bottles with a capacity of 30 ml and 50 ml, with a dropper, a cap with a guarantee ring, and a measuring cup, in a cardboard box.
Characteristic of this product is the gradual yellowing of the emulsion.
For more detailed information, you should contact the marketing authorization holder or the parallel importer.
Berlin-Chemie AG (Menarini Group)
Glienicker Weg 125
12489 Berlin
Germany
Berlin-Chemie AG (Menarini Group)
Glienicker Weg 125
12489 Berlin
Germany
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Delfarma Sp. z o.o.
ul. Św. Teresy od Dzieciątka Jezus 111
91-222 Łódź
Authorization number in Romania, the country of export:
8749/2016/01
8749/2016/02
Bulgaria
Еспумизан комфорт 100 mg/ml перорални капки, емулсия
Czech Republic
Espumisan
Estonia
Espumisan 100 mg/ml
Hungary
Espumisan 100 mg/ml belsőleges emulziós cseppek
Latvia
Espumisan 100 mg/ml pilieni iekšķīgai lietošanai, emulsija
Poland
Espumisan 100 mg/ml
Romania
Espumisan 100 mg/ml, picături orale, emulsie
Slovenia
Espumisan 100 mg/ml, peroralne kapljice, emulzija
Slovakia
Espumisan comfort 100 mg/ml perorálne emulzné kvapky
[Information about the trademark]
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for Espumisan 100 mg/ml – subject to medical assessment and local rules.